Overall, these results show that KRAS-silenced HCT116 cells responded to fibroblast-secretome by modulating transcription and by decreasing the expression of proteins associated with the cytoskeleton, focal adhesions, and cell–cell junctions, thus representing key proteins involved in essential cancer cell functions, such as motility. The gene discussed is KRAS; the disease is cancer.